<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05036330</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1114</org_study_id>
    <secondary_id>NCI-2021-08784</secondary_id>
    <secondary_id>2020-1114</secondary_id>
    <nct_id>NCT05036330</nct_id>
  </id_info>
  <brief_title>ProvoxLife Adoption Trends for Heat-Moisture Exchanger</brief_title>
  <official_title>ProvoxLifeÂ® Adoption Trends for Heat-Moisture Exchanger (HME): The PATH Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines factors that affect how often patients who have a total laryngectomy use&#xD;
      a ProvoxLife heat-moisture exchanger (HME) system to help improve their lung function.&#xD;
      ProvoxLife HMEs are single use heat- and moisture exchangers for patients breathing through a&#xD;
      tracheostoma. Information from this study may help doctors learn more about factors&#xD;
      associated with patterns of use and how often patients use the ProvoxLife HME system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To determine clinical and patient factors associated with patterns of use of the&#xD;
      ProvoxLife HME system for pulmonary rehabilitation after total laryngectomy.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To explore outcomes associated with patterns of ProvoxLife HME system. II. To explore&#xD;
      factors associated with post-laryngectomy outcomes.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo speech and swallow evaluation by speech pathologist or study staff member&#xD;
      and examination of tracheoesophageal puncture (TEP) and laryngectomy stoma. Patients also&#xD;
      complete questionnaires over 30 minutes about use the ProvoxLife HME system, symptoms,&#xD;
      ability to communicate, exercise and physical activity levels, and quality of life at&#xD;
      baseline and 3 months post-ProvoxLife.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine clinical and patient factors associated with patterns of use of the ProvoxLife HME system for pulmonary rehabilitation after total laryngectomy.</measure>
    <time_frame>Up to 3 months post-ProvoxLife HME</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Malignant Head and Neck Neoplasm</condition>
  <arm_group>
    <arm_group_label>Observational (evaluation, examination, questionnaire)</arm_group_label>
    <description>Patients undergo speech and swallow evaluation by speech pathologist or study staff member and examination of TEP and laryngectomy stoma. Patients also complete questionnaires over 30 minutes about use the ProvoxLife HME system, symptoms, ability to communicate, exercise and physical activity levels, and quality of life at baseline and 3 months post-ProvoxLife.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical Evaluation</intervention_name>
    <description>Undergo speech and swallow evaluation</description>
    <arm_group_label>Observational (evaluation, examination, questionnaire)</arm_group_label>
    <other_name>Clinical Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physical Examination</intervention_name>
    <description>Undergo examination of TEP and laryngectomy stoma</description>
    <arm_group_label>Observational (evaluation, examination, questionnaire)</arm_group_label>
    <other_name>Assessment</other_name>
    <other_name>General Examination</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Complete questionnaires</description>
    <arm_group_label>Observational (evaluation, examination, questionnaire)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete questionnaires</description>
    <arm_group_label>Observational (evaluation, examination, questionnaire)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients using or planning to use HME as part of standard care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults &gt;= 18 years of age planned for or status post total laryngectomy&#xD;
&#xD;
          -  Using or ready for fit of HME system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active malignancy if post-total laryngectomy (TL) at the time of enrollment&#xD;
&#xD;
          -  Unable to complete questionnaires in English language&#xD;
&#xD;
               -  The primary endpoint derives from a study specific questionnaire, due to limited&#xD;
                  resources, is only available in English language&#xD;
&#xD;
          -  Cognitive or other limitations that preclude independent self-care or completion of&#xD;
             questionnaires&#xD;
&#xD;
               -  Cognitive or other limitations that preclude independent self-care or completion&#xD;
                  of questionnaires will be assessed in the screening interview by the clinical or&#xD;
                  research team&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine A Hutcheson</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine A. Hutcheson</last_name>
      <phone>713-792-6513</phone>
      <email>karnold@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Katherine A. Hutcheson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

